Latest filing published 08 Aug 2023 for Adaptive Biotechnologies Corp, €35k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Nitin Sood: trading record in brief
All filings by Nitin Sood on record concern Adaptive Biotechnologies Corp, in the capacity of senior executive. The record holds 9 filings, for trades running from 16 August 2021 to 8 August 2023.
On the market, this insider has only sold: 6 sales, €670k in total. Besides market trades, the filings include 3 share grants. So far in 2023, the count stands at no purchases and 4 sales.
On 8 August 2023 came the latest disclosure, an open-market sale for €35k in Adaptive Biotechnologies Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nitin Sood
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,652 shares@ US$6.786.5% of flowCommon StockSEC:0001062993-23-016018:0
- 10,550 shares@ US$6.5411.7% of flowCommon StockSEC:0001062993-23-016018:1
- 132,979 shares0Common StockSEC:0001062993-23-006324:0
- 31,066 shares@ US$8.0046.8% of flowCommon StockSEC:0001209191-22-055170:0
- 17,540 shares@ US$10.9835.0% of flowCommon StockSEC:0001209191-22-044688:0
- 65,898 shares0Common StockSEC:0001209191-22-017400:0
- 97,213 shares0Common StockSEC:0001209191-21-052344:0
7 of 7 declarations
